logo
Impact Radar
  • Overview
  • Impact Performance
  • Compare this company
  • All sources
    • Sign UpLog In
    logo

    Genmab | Sustainability & Chart

    DK0010272202

    Basic information on Genmab

    Location: Denmark

    Industry: Health Services

    Website

    knob-globe
    54%

    Impact Score

    Description Genmab

    Genmab A/S is a biotechnology company that specializes in the creation and development of human antibody therapeutics for the treatment of cancer and other diseases.

    Genmab Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable [100]
    Almost sustainable [67-99]
    Moderate [34-66]
    Not sustainable [0-33]
    No data
    We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

    Compare Genmab with ...

    Genmab

    ?

    Impact Score

    knob-globe
    54%
    knob-globe
    0%
    Climate
    Society
    Gender

    Sources of sustainability performance

    MetricValueUnitYearPDF NamePDF Page
    CEO Pay Ratio
    CEO-to-median-salary-ratio76Ratio20252025-annual-report.pdf89
    CEO nameJan van de Winkel20252025-annual-report.pdf7
    Employee Turnover Rate
    Employee turnover12%20252025-annual-report.pdf87
    Gender Pay Gap
    Unadjusted gender pay gap9%20252025-annual-report.pdf89
    Glass Ceiling
    Women in management30%20252025-annual-report.pdf86
    Women in workforce1 598Headcount20252025-annual-report.pdf87
    Number of employees2 819Employees20252025-annual-report.pdf87
    Greenhouse Gas Emissions
    Scope 2 emissions, location based2 658(tCO2eq)20252025-annual-report.pdf76
    Number of employees2 819Employees20252025-annual-report.pdf87
    Scope 1 emissions758(tCO2eq)20252025-annual-report.pdf76
    Harassment and Discrimination at the Workplace
    Incident notification mechanismYes20252025-annual-report.pdf94
    Retaliation safeguardsYes20252025-annual-report.pdf99
    Anti-discrimination policyYes20252025-annual-report.pdf83
    Confidentiality mechanismsYes2025Genmab_Code of Conduct_2023_EN.pdf8
    Renewable Energy
    Total renewable energy consumption65%20252025-annual-report.pdf76
    Supply Chain
    Scope 2 emissions, location based2 658(tCO2eq)20252025-annual-report.pdf76
    Number of employees2 819Employees20252025-annual-report.pdf87
    Scope 1 emissions758(tCO2eq)20252025-annual-report.pdf76
    Scope 3 emissions219 450(tCO2eq)20252025-annual-report.pdf76
    Union Formation and Collective Bargaining Power
    Number of employees2 819Employees20252025-annual-report.pdf87
    Collective bargaining agreements coverage0employees20252025-annual-report.pdf87
    Women on the Board
    Women on executive board2people20252025-annual-report.pdf56
    Executive board size9people20252025-annual-report.pdf56
    Supervisory board size9people20252025-annual-report.pdf57
    Women on supervisory board4people20252025-annual-report.pdf57
    Women in Management
    Women in management30%20252025-annual-report.pdf86
    Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

    Find more sustainable companies

    logo
    HomeFind Companies & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact Us
    © 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev